Table 3.

Multivariate Predictors of CAC Progression.

	Model 1 Baseline Predictors	Model 2: Baseline Predictors + CAC at Baseline	Model 3: Subset with CAC at Baseline
	N=346	N=346	N=154
	RR (95% CI)	RR (95% CI)	RR (95% CI)
Black Race	0.68 (0.45,1.03)	0.66 (0.44,0.98)*	0.65 (0.43,0.99)*
Age†	1.32 (1.08,1.62)‡	1.12 (0.91,1.38)	1.10 (0.89,1.36)
BMI†	1.31 (1.11,1.54)‡	1.06 (0.90,1.25)	1.05 (0.88,1.25)
SBP†	1.28 (1.06,1.55)*	1.23 (1.06,1.44)‡	1.24 (1.06,1.46)‡
Use of statins‡	1.65 (0.96,2.83)§	1.45 (0.78,2.68)	1.38 (0.71,2.68)
Education ≤ High School	1.52 (1.02,2.27)*	1.47 (0.99,2.20)§	1.55 (1.03,2.33)*
Presence of CAC at Baseline		4.68 (2.43,9.01)||
CES-D scores †	1.25 (1.06,1.47)‡	1.26 (1.10,1.44)||	1.31 (1.13,1.51)||

^†standardized

^§p<.10,

^*p<.05,

^‡p<.01,

^||p<.001

Adjusted for time between scans, post-menopausal status and HT use (all non-significant at p=0.10).

^‡cholesterol lowering medication